July 22, 2024

New whitepaper with Georgia Cancer Center highlights value of Lung Cancer Prediction AI

 

 

new whitepaper released with Georgia Cancer Center shows how Optellum’s Virtual Nodule Clinic (VNC) has helped transform their management of incidentally detected lung nodules. This innovative program, led by Dr. Daniel Miller, uses advanced AI technology to swiftly assess nodule risks and streamline diagnostic processes.

With Optellum’s AI-driven insights, the center now accurately identifies high-risk nodules, facilitating timely treatment such as robotic bronchoscopy or surgical biopsy. The integration of Optellum’s Lung Cancer Prediction (LCP) scores allows Dr. Miller and his team to focus on targeted, effective patient care, reducing unnecessary procedures and improving diagnostic efficiency.

The success of the Optellum VNC at Georgia Cancer Center highlights a major advancement in personalized lung nodule management, ensuring patients receive tailored care aligned with their specific risk profiles.

“It’s about finding the patients…, and accelerating their time to diagnosis, care, and, ultimately, cure… The right procedures for the right patients”.

— Dr. Daniel Miller, Director of Thoracic Surgery and Chair in Surgical Oncology, Georgia Cancer Center at Augusta University

Read the full whitepaper here (sign up required)

Recent posts

August 24, 2026 / News & Press, Partnerships
SimonMed Launches World’s First Seamlessly Integrated AI Lung Nodule Risk Assessment Workflow
SimonMed is creating the first fully automated AI-powered lung cancer risk assessment workflow deployed at enterprise scale, combining multiple FDA-cleared AI technologies into a...
Read more
August 13, 2026 / News & Press, Partnerships
Coreline Soft and Optellum announce intent to collaborate to advance AI...
Proposed collaboration would make Coreline Soft's FDA-cleared lung nodule detection capability available through Optellum's LungOS® platform
Read more
June 15, 2026 / News & Press, Partnerships
Optellum Awarded NIHR Funding for Multi-Site NHS Pilot Study for Accelerated...
Optellum announced it has been awarded funding for a competitive programme, Invention for Innovation (i4i), focused on transformative and disruptive innovations to reduce waiting...
Read more
Optellum is trusted by industry & academic leaders
IntuitiveJohnson & JohnsonConcert AIGE HealthcareNHSUniversity of OxfordVanderbilt University Medical CenterAtrium HealthPenn MedicineUConn HealthJupiter Medical CenterGeorgia Cancer Center Augusta University
IntuitiveJohnson & JohnsonConcert AIGE HealthcareNHSUniversity of OxfordVanderbilt University Medical CenterAtrium HealthPenn MedicineUConn HealthJupiter Medical CenterGeorgia Cancer Center Augusta University
IntuitiveJohnson & JohnsonConcert AIGE HealthcareNHSUniversity of OxfordVanderbilt University Medical CenterAtrium HealthPenn MedicineUConn HealthJupiter Medical CenterGeorgia Cancer Center Augusta University
Certification
Redefining early intervention of lung disease starting with one of the deadliest, lung cancer
Contact us